|
Jul 12
|
Hims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer
|
|
Jul 12
|
Novo Nordisk A/S (NVO): “Canada’s A Backdoor,” Says Jim Cramer
|
|
Jul 12
|
Bull of the Day: Hims & Hers Health (HIMS)
|
|
Jul 11
|
Smart Money Going in Senior Health: Key Stocks in Elderly Care
|
|
Jul 11
|
Can Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?
|
|
Jul 11
|
WeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?
|
|
Jul 11
|
June in Review: 14 Top Health Press Releases
|
|
Jul 2
|
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
|
|
Jul 2
|
Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements
|
|
Jul 2
|
Is Hims & Hers Stock in Trouble?
|
|
Jul 2
|
2 Growth Stocks to Buy Hand Over Fist in July
|
|
Jul 2
|
This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
|
|
Jul 1
|
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
|
|
Jul 1
|
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
|
|
Jul 1
|
Sector Update: Health Care Stocks Advance Tuesday Afternoon
|
|
Jul 1
|
Top Midday Stories: Powell Blames Tariffs for Rate Pause; Tesla Shares Fall on Trump-Musk Feud
|
|
Jul 1
|
Update: Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch
|
|
Jul 1
|
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
|
|
Jul 1
|
Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch
|
|
Jul 1
|
How Novo Nordisk misread the US market for its weight loss sensation
|